Tag: nutraceuticals

SupplySide Connect Madison is set to launch as a pivotal new event for professionals in the food, beverage, and dietary supplement industries across the Midwest, aiming to foster connections, collaboration, and innovation. Scheduled to take place on June 8-9, 2027, at the Monona Terrace Community and Convention Center in Madison, Wisconsin, this event signifies a…

September 17, 2026 – Irish biotechnology firm Nova Mentis has launched a novel, precision-fermented form of hydroxytyrosol, a powerful polyphenol derived from olives, aiming to capitalize on the sustained global interest in the Mediterranean diet and its associated health benefits. This innovative approach promises a highly pure and consistently available source of the compound, addressing…

SupplySide Connect New Jersey is set to make its return to the Meadowlands Exposition Center on April 4-5, 2028, promising a dynamic two-day event dedicated to fostering innovation, forging strategic partnerships, and strengthening community within the burgeoning health and nutrition sector. This anticipated gathering aims to serve as a pivotal nexus for industry professionals, offering…

The dietary supplement industry, particularly its botanical sector, is navigating a period of significant transition, with companies closely monitoring shifts within the U.S. Food and Drug Administration (FDA) and their potential impact in the coming year. Addressing these concerns, Hellen Oketch-Rabah, Ph.D., deputy director of the FDA’s Office of Dietary Supplement Programs (ODSP), delivered a…

The American Herbal Products Association (AHPA) Botanical Congress, held on September 15th, illuminated the critical, yet often overlooked, role of herb farmers in sustaining the burgeoning dietary supplement industry. As Erika Craft of Nutrition Business Journal highlighted, herbs and botanicals represent the third-largest segment of the supplement market and are its third-fastest growing category, a…

A pivotal joint workshop convened by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on September 25, 2026, aimed to delineate and streamline the regulatory pathways for botanical drugs in both major global markets. Held at the EMA headquarters in Amsterdam, the early-morning session, which necessitated an inconvenient start for…

The newest legislative development in this evolving landscape is California’s Assembly Bill 2030 (AB 2030), signed into law by Governor Gavin Newsom on October 2, 2026. This bill introduces significant restrictions on the sale of certain dietary supplements and over-the-counter diet pills, specifically targeting consumers under the age of 18. AB 2030 prohibits the sale…

The dietary supplement industry is currently witnessing a significant surge in innovation, driven by a confluence of critical trends. Emerging research and market demand are highlighting the intricate connections between women’s health, weight management strategies, advancements in botanical ingredient research, and the development of new products tailored for postnatal recovery and perimenopausal support. This edition…

A significant legal development in the dietary supplement industry has seen a federal court invalidate key claims in a patent held by Kaneka Corporation, a prominent manufacturer of ubiquinol, also known as reduced coenzyme Q10 (CoQ10). The ruling, issued on September 2nd by the U.S. District Court for the Eastern District of New York, declared…

A pivotal piece of legislation, the Dietary Supplement Innovation Act, has garnered significant backing from a broad spectrum of industry organizations. This bill, spearheaded by Representative Diana Harshbarger (R-Tenn.), is designed to untangle a complex and often contentious issue: the drug preclusion clause within the Dietary Supplement Health and Education Act of 1994 (DSHEA). For…